Amer. Financial Grp.

AFG made $8.2 billion in annual revenue, but earnings still fell 4% in 2025. Insurance math gets weird fast.

If you own AFG, you own a steady insurer with one very unsteady earnings line.

afg

financials large cap updated mar 29, 2026
$128.95
market cap ~$11B · 52-week range $115–$137
xvary composite: 64 / 100 · average
our overall rating — combines growth, value, risk, and momentum
Start here if you're new
what it is
AFG sells niche business insurance, from crop coverage to transportation policies, and lives on pricing discipline.
how it gets paid
Last year Amer. Financial Grp made $8.2B in revenue. Property and Transportation was the main engine at $2.8B, or 34% of sales.
why growth slowed
Revenue fell 1.8% last year. The key number was the 11.96% EPS beat.
what just happened
Latest quarter EPS came in at $3.65, beating the $3.26 estimate by 11.96%.
At a glance
A balance sheet — strong enough to weather a downturn
80/100 earnings predictability — you can trust these numbers
12.5x trailing p/e — the market's not buying it — or you found a deal
3.1% dividend yield — cash in your pocket every quarter
14.9% return on capital — nothing to write home about
xvary composite: 64/100 — average
What they do
AFG sells niche business insurance, from crop coverage to transportation policies, and lives on pricing discipline.
AFG stays in specialized commercial insurance instead of picking a price war with everyone else. That focus helped it keep a 13.1% operating margin, while the stock still trades at 12.5x earnings. Specialized commercial insurance means harder-to-copy policies for messy risks, so what: you are paying for underwriting skill, not a commodity product.
financials mid-cap insurance income specialty-p-c
How they make money
$8.2B annual revenue · their business grew -1.8% last year
Property and Transportation
$2.8B
Specialty Casualty
$2.5B
Specialty Financial
$2.3B
Other underwriting and investment income
$0.6B
The products that matter
specialty commercial insurance
Specialty Commercial P&C
~90% of revenue
it's roughly 90% of the business now, so your results hinge on underwriting niche commercial risks better than competitors do.
90% of revenue
shareholder payout engine
Dividend Growth
12.7% hike in 2025
the dividend rose 12.7% in 2025 and the streak reached 19 straight years. That tells you management still sees enough capital cushion to return cash.
19-year streak
portfolio reshaping
Sold Annuity Business
$3.6B sale in 2021
the $3.6B sale in 2021 made the company simpler and more focused. In human-speak: less capital-heavy life exposure, more pure-play specialty insurance.
$3.6B sale
Key numbers
3.1%
dividend yield
Dividend yield means cash paid to you each year relative to price, so what: this stock pays you 3.1% while you wait for earnings to recover.
12.5x
trailing p/e
Price-to-earnings means what investors pay for each $1 of profit, so what: AFG is priced like a slow, boring insurer even after a strong fourth quarter.
14.9%
return on capital
Return on capital means profit generated from the money tied up in the business, so what: AFG still turns capital into earnings better than many sleepy financials.
4.5%
projected eps growth
EPS growth means how fast profit per share is expected to rise, so what: the outlook is slower than the 7.0% historical pace, which argues against paying up.
Financial health
A
strength
  • balance sheet grade A — very strong financial position
  • risk rank 2 — safer than 80% of stocks
  • price stability 90 / 100
  • return on equity 14% — $0.14 profit for every $1 investors have put in
A — among the top-rated companies for balance sheet quality.
Total return vs. market

You invested $10,000 in AFG 3 years ago → it's now worth $11,410.

The index would have given you $13,880.

source: institutional data · total return
What just happened
beat estimates
Latest quarter EPS came in at $3.65, beating the $3.26 estimate by 11.96%.
Q4 2025 net revenue was about $2.06B (roughly +2% vs. prior-year quarter per recap headlines). Core operating EPS was $3.65 (diluted net EPS about $3.58). Full-year 2025 core operating EPS was about $10.29; net EPS was about $10.08—compare those labels to screens before you mix GAAP and “core.”
~$2.06B
Q4 net revenue
$3.65
Q4 core op. EPS
n/a
n/a
the number that mattered
The key number was the 11.96% EPS beat, because it shows AFG can still surprise upward even after a softer full year.
sources: AFG Q4/FY2025 materials · afginc.com/investors · recap: MarketScreener / FinancialContent (Feb. 2026)

Get this snapshot in your inbox

This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.

weekly updates earnings alerts plain english no spam
What could go wrong

the #1 risk is catastrophe losses hitting specialty property and crop lines at the same time.

med
catastrophe loss spike
A major hurricane, wildfire, or severe loss year can overwhelm otherwise normal underwriting results. That's not abstract. Management already pointed to the los angeles wildfires as part of the 2025 pressure.
The current stress frame on this page is blunt: a 1-in-100 year event could wipe out more than $1B of capital.
med
interest rate reversal
Insurers invest the premium float in bonds. In plain English: they collect premiums now and earn income before claims are fully paid out. That means lower rates hit part of the earnings story even if underwriting stays decent.
The current page estimate says a 1% drop in rates could reduce annual investment income by about $80M.
med
family succession
The same family ownership that creates alignment also concentrates power. Family-controlled companies look great until succession moves from theory to execution.
The page's current framework flags a 5–10% valuation premium at risk if a transition is handled poorly.
catastrophe losses and lower investment income would hit both engines at once — underwriting profits and float income. That's how a cheap insurer gets cheaper.
source: institutional data · regulatory filings · risk analysis
Pay attention to
earnings
next earnings report
The April 30, 2026 report should tell you whether Q4's underwriting rebound was the start of a trend or one clean quarter.
risk
crop and catastrophe normalization
Management already warned against assuming another unusually favorable crop year. If that tailwind fades while catastrophe losses rise, estimates get harder to defend.
valuation
whether 12.5x earnings starts to move
Cheap insurers stay cheap when the market doubts the quality of earnings. If 2026 numbers firm up, that discount has room to narrow toward the $147 target.
flow
institutional selling pressure
Institutions have been net sellers for 2 straight quarters. That's mild caution, not panic, but you want to see that trend stop if the recovery thesis is real.
Analyst rankings
short-term outlook
below average
outlook rank 4 — analysts see below-average price performance in the near term. in human-speak, they want another clean quarter before they get excited.
risk profile
above average
risk rank 2 — safer than roughly 80% of stocks. that's balance sheet safety, not immunity from weather or reserve noise.
chart momentum
top 20%
momentum rank 2 — the stock's recent price action has been better than the full-year headline would suggest.
earnings predictability
80 / 100
earnings are relatively reliable for an insurer. you still get weather and cycle noise, but not roulette-wheel noise.
source: institutional data
Institutional activity

institutions have been net selling for 2 consecutive quarters — 221 buyers vs. 226 sellers in 3q2025. total institutional holdings: 57.7M shares. net selling for 2 quarters.

source: institutional data
Price targets
3-5 year target range
$107 $186
$129 current price
$147 target midpoint · +14% from current · 3-5yr high: $215 (+65% · 16% ann'l return)
source: institutional data · analyst targets

Want the deeper analysis?

The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.

see plans from $5/mo
The deep dive
AFG
xvary deep dive
afg
the full analysis is in the works.
what you'll get
dcf valuation model
bull / base / bear scenarios
competitive moat breakdown
quarterly earnings tracker
operating model projections
risk matrix with kill criteria
original price target + conviction
updated with every earnings
free · no spam · you'll be first to read it